Immune checkpoint inhibitors and response analysis: a tough challenge. A case report

por Bearz, Alessandra, Perin, Tiziana, Cancian, Luca, Berto, Eleonora, Sartor, Ivana, Tirelli, Umberto
Publicado 2016

Brain Metastases Management in Oncogene-Addicted Non-Small Cell Lung Cancer in the Targeted Therapies Era

por De Carlo, Elisa, Bertoli, Elisa, Del Conte, Alessandro, Stanzione, Brigida, Berto, Eleonora, Revelant, Alberto, Spina, Michele, Bearz, Alessandra
Publicado 2022

Outcomes of ALK positive lung cancer patients treated with crizotinib or second-generation ALK inhibitor: a monoinstitutional experience

por De Carlo, Elisa, Del Savio, Maria Chiara, Polesel, Jerry, Da Ros, Valentina, Berto, Eleonora, Santarossa, Sandra, Chimienti, Emanuela, Fratino, Lucia, Bearz, Alessandra
Publicado 2018

Therapeutic decision based on molecular detection of resistance mechanism in an ALK-rearranged lung cancer patient: a case report

por De Carlo, Elisa, Schiappacassi, Monica, Urbani, Martina, Doliana, Roberto, Baldassarre, Gustavo, Da Ros, Valentina, Santarossa, Sandra, Chimienti, Emanuela, Berto, Eleonora, Fratino, Lucia, Bearz, Alessandra
Publicado 2018

Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience

por Bearz, Alessandra, Talamini, Renato, Rossoni, Gilda, Santo, Antonio, de Pangher, Vincenzo, Fasola, Gianpiero, Rosetti, Francesco, Favaretto, Adolfo, Gregorc, Vanesa, Berretta, Massimiliano, Santarossa, Sandra, Berto, Eleonora, Tirelli, Umberto
Publicado 2012